Is NAMS stock a Buy, Sell, or Hold?

Based on our analysis, NAMS is currently a HOLD with low confidence. 📊 HOLD: NAMS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

What is the fair value of NAMS stock?

Our analysis estimates the fair value range for NAMS to be between $29.63 and $34.93. The current price is $27.79.

What is the analyst price target for NAMS?

The average Wall Street analyst price target for NAMS is $51.41. This implies a potential upside of 85.0% from current levels.

NAMS Stock Analysis: Buy, Sell, or Hold?

NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares

PHARMACEUTICAL PREPARATIONS

$27.79

-0.67 (-2.35%) ▼

5d: -6.24%

30d: -20.98%

90d: -2.7%

HOLD

LOW Confidence

Protect Your NAMS Gains

Analysis Updated: Jul 31, 2026 12:00 AM ET

Earnings: Aug 05, 2026 1d

Smart Money Distribution

None View Scanner →

Strength: 3.8/10

Get Alerted When NAMS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: NAMS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NAMS is currently trading at $27.79, which is considered oversold relative to its 30-day fair value range of $29.63 to $34.93.

Technical Outlook: Technically, NAMS is showing sideways momentum. The price is currently testing key support at $26.99. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: NAMS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $51.41 (+85.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $29.63 - $34.93

Company Quality Score 50/100 (HOLD)

Options IV Signal 30th percentile (NORMAL)

Volume Confirmation HIGH

Confidence Score 60.4%

Protect Your Profits

Holding NAMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Options fairly priced (IV 30th percentile)
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 85.0% below Wall St target ($51.41)
CAUTION: Recommendation downgraded due to -6.2% 5-day decline

Trading Range Analysis

30-Day Trading Range $29.63 - $34.93

Current vs Trading Range OVERSOLD

Expected Move (7 Days) ±$3.70 (13.3%)

Support & Resistance Levels

Support Level $26.99

Resistance Level $32.63

Current Trend Sideways

Technical data as of Jul 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) -21.14

Wall Street Target $51.41 (+85.0%)

Revenue Growth (YoY) 2.1%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 03, 2026 1:02 AM ET
Data refreshes hourly during market hours. Next update: 2:02 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is NAMS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Louis G Lange SELL 44619 shares 2026-03-11

Johannes Jacob Piete Kas… SELL 101409 shares 2026-03-09

Johannes Jacob Piete Kas… SELL 94124 shares 2026-03-06

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for NAMS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
CRSP Crispr Therapeutics AG	BUY 28 analysts	$87	53 HOLD
INSM Insmed Inc	STRONG BUY 21 analysts	$196	47 HOLD
VRTX Vertex Pharmaceuticals I…	BUY 34 analysts	$557	49 HOLD
CYTK Cytokinetics Inc	STRONG BUY 21 analysts	$108	60 HOLD
CRNX Crinetics Pharmaceutical…	STRONG BUY 17 analysts	$86	47 HOLD

CRSP Crispr Therapeuti…

53 HOLD

INSM Insmed Inc

47 HOLD

VRTX Vertex Pharmaceut…

49 HOLD

CYTK Cytokinetics Inc

60 HOLD

CRNX Crinetics Pharmac…

47 HOLD

Advanced NAMS Option Strategies

Professional options setups generated by AI based on today's NAMS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NAMS

NAMS Technical Chart NAMS Price Prediction NAMS Earnings Date NAMS Investment Advisor NAMS Fair Price Analyzer NAMS Options Advisor NAMS Options Chain NAMS Options Analysis NAMS Competitors

Compare NAMS with Peers

NAMS vs MLYS
Which one to buy?

NAMS vs EWTX
Which one to buy?

NAMS vs IRON
Which one to buy?

NAMS vs APGE
Which one to buy?

NAMS vs ELVN
Which one to buy?

ABVX vs NAMS

ABVC vs NAMS
Winner: NAMS

AAOI vs NAMS
Winner: AAOI

ABVE vs NAMS

TLX vs NAMS

NAMS vs ZLAB

Create New Comparison View All Competitors

Tradestie